Nothing really new for the pharmaceutical community tbh. The MRSA - which is probably the most well known superbug - has been around for years and claimed more deaths than AIDS per year in the US last time I checked.

There was an article pointing out that a techniques based on combination of ATBs + Bacteriophages might be a possible replacement. Another possible counter-measure is nano-tech.

If states do not jump-in funding various research groups, it's highly unlikely that humanity will be given another "Aha!" moment a-la Fleming.